Clinical observation of cerebral infarction with Edaravone
Yan Hai-qing
Abstract
Yan Hai-qing
Abstract
Objective:To observe the effect of cerebral infarction of Edaravone. Methods: 80 cases of cerebral infarction pa- tients selected were divided into two groups. 40 cases of control group patients were given conventional treatment ,40 cases of observation group patients were given the conventional therapy plus Edaravone 30 mg ivgtt q12 h. Results:14 d after the treatment,TNF-α in cerebrospinal fluid in the edaravone treatment group more significantly reduced than that in the control group (P0.05); Edaravone treatment group the14 d neurological deficit scores of the Edaravone treatment gruoup improved more sig- nificantly than the control group (P0.05). Conclusion:Edaravone can effectively improve the acute cerebral neurological deficits, efficacy, and worthy of clinical application.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To observe the effect of cerebral infarction of Edaravone. Methods: 80 cases of cerebral infarction pa- tients selected were divided into two groups. 40 cases of control group patients were given conventional treatment ,40 cases of observation group patients were given the conventional therapy plus Edaravone 30 mg ivgtt q12 h. Results:14 d after the treatment,TNF-α in cerebrospinal fluid in the edaravone treatment group more significantly reduced than that in the control group (P0.05); Edaravone treatment group the14 d neurological deficit scores of the Edaravone treatment gruoup improved more sig- nificantly than the control group (P0.05). Conclusion:Edaravone can effectively improve the acute cerebral neurological deficits, efficacy, and worthy of clinical application.
Key concepts: Edaravone, Medicine, Anesthesia, Clinical efficacy, Cerebral infarction, Neurological deficit, Surgery, Internal medicine